Key facts
- This page summarizes Eric Topol's Form 4 filing for DEXCOM INC (DXCM).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 23 May 2022, 17:08.
Eric Topol - 20 May 2022 Form 4 Insider Report for DEXCOM INC (DXCM)
- Reporting relationship
- Director
- Issuer ticker
- DXCM
- Reported as of
- 20 May 2022
- Net transaction value
- +$0.988
- SEC form
- 4
- Accepted by SEC
- 23 May 2022, 17:08:25 UTC
- Prior SEC filing
- 25 May 2021
- Next SEC filing
- 22 May 2023
- Source filing
- View source filing
- Reporting owner signature
- By: Jereme Sylvain For: Eric Topol
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eric Topol filed Form 4 for DEXCOM INC (DXCM) on 23 May 2022.
Change
- Previous filing in this sequence was filed on 25 May 2021.
- Current net transaction value: +$0.988.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DXCM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -919
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 19 May 2022
- Ownership
- Direct
- Footnotes
- F1
DXCM
transaction
Common Stock
Award
- Transaction value
- $0.988
- Shares
- +988
- Change %
- Price
- $0.001000*
- Shares after
- 988
- Date
- 20 May 2022
- Ownership
- Direct
- Footnotes
- F2, F3
DXCM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +919
- Change %
- +1%
- Price
- $0.000000
- Shares after
- 92,766
- Date
- 19 May 2022
- Ownership
- Family Holdings
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units.
Footnote F2
The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
Footnote F3
Represents 988 restricted stock units which were granted on May 20, 2022 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting.
Footnote F4
Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares.